Association analysis of a neural nitric oxide synthase gene polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients

Journal of Neural Transmission

Volumn 111, Issue 5, 2004, Pages 623-629

  Wang, Y C ^a,b   Liou, Y J ^a,c   Liao, D L ^d   Bai, Y M ^a,c   Lin, C C ^a   Yu, S C ^e   Chen, J Y ^a  

^a YULI VETERANS HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Pali Psychiatric Hospital   (Taiwan)

^e Yuli Hospital Department of Health Taiwan   (Taiwan)

Author keywords

Antipsychotics; Association study; Neural nitric oxide synthase; NOS1; Polymorphism; Tardive dyskinesia

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT; NEURONAL NITRIC OXIDE SYNTHASE;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NITRIC OXIDE SYNTHASE 1 GENE; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; CHINA; DYSKINESIA, DRUG-INDUCED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTORY, 16TH CENTURY; HUMANS; MALE; MIDDLE AGED; NEURONS; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 1942532731     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0118-y     Document Type: Article

References (22)

1. Bester AM, Harvey BH (2000) Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movements. Metab Brain Dis 15: 275-285
2. Cadet JL, Lohr JB (1989) Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E. Ann NY Acad Sci 570: 176-185
3. Casey DE (1999) Tardive dyskinesia and atypical antipsychotic drugs. Schizophr Res 35 [Suppl]: S61-S66
4. Hall AV, Antoniou H, Wang Y, Cheung AH, Arbus AM, Olson SL, Lu WC, Kau CL, Marsden PA (1994) Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 269: 33082-33090
5. Harvey BH, Nel A (2003) Role of aging and striatal nitric oxide synthase activity in an animal model of tardive dyskinesia. Brain Res Bull 61: 407-416
6. Karatinos J, Rosse RB, Deutsch SI (1995) The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders. Clin Neuropharmacol 18: 482-499
7. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5: 1403-1409
8. Lohr JB, Caligiuri MP (1996) A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 57: 167-173
9. Lohr JB, Kuczenski R, Bracha HS, Moir M, Jeste DV (1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry 28: 535-539
10. Lohr JB, Kuczenski R, Niculescu AB (2003) Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17: 47-62
11. Mahadik SP, Mukherjee S (1996) Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res 19: 1-17
12. Naidu PS, Kulkarni SK (2001) Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide. Behav Pharmacol 12: 209-216
13. Nel A, Harvey BH (2003) Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine. Behav Pharmacol 14: 251-255
14. Post A, Holsboer F, Behl C (1998) Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. J Neurosci 18: 8236-8246
15. Sachdev P, Saharov T, Cathcart S (1999) The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia. Biol Psychiatry 46: 1672-1681
16. Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39: 486-487
17. Shinkai T, Ohmori O, Hori H, Nakamura J (2002) Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 7: 560-563
18. Simmons ML, Murphy S (1992) Induction of nitric oxide synthase in glial cells. J Neurochem 59: 897-905
19. Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC, Kandel ER (1996) Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 87: 1015-1023
20. Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220: 530-532
21. Wang Y, Newton DC, Marsden PA (1999) Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit Rev Neurobiol 13: 21-43
22. Yu YW, Chen TJ, Wang YC, Liou YJ, Hong CJ, Tsai SJ (2003) Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology 47: 137-140